Trade SNSE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Sensei Biotherapeutics Inc (SNSE) is trading at US$13.85, up 0.00% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$17.45M. Over the past 52 weeks, SNSE has traded between US$7.45 and US$36.76. On Syfe you can trade SNSE with $0 commission and add it to your watchlist.
| Previous close | US$13.85 |
|---|---|
| Market cap | US$17.45M |
| 52-week range | US$7.45 – US$36.76 |
| Volume | 219.73K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Sensei Biotherapeutics Inc
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
Year: 2021
--Cantor Fitzgerald Initiates Sensei Biotherapeutics at Overweight
May 29, 10:27 AM · MT Newswires
Leerink Partners Initiates Coverage on Sensei Biotherapeutics With Outperform Rating, $50 PT
Apr 20, 11:14 AM · MT Newswires
Sensei Biotherapeutics Inc (SNSE) stock is trading at US$13.85, 0.00% from the previous close of US$13.85.
The market cap for Sensei Biotherapeutics Inc (SNSE) stock is approximately US$17.45M.
The 52-week high for Sensei Biotherapeutics Inc (SNSE) stock is US$36.76.
The 52-week low for Sensei Biotherapeutics Inc (SNSE) stock is US$7.45.
Sensei Biotherapeutics Inc (SNSE) does not currently pay a dividend.
Stay on top of SNSE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
